Patient Survey to Inform Trikafta Drug Review
As the life changing cystic fibrosis medicine, Trikafta, continues to rapidly move through Canada’s drug review and reimbursement system, Cystic Fibrosis Canada is conducting a…
Read More
A look ahead to 2021
It is with optimism that we welcome the year 2021. With this new year comes our renewed pledge to go even further for people living with…
Read More
ADVOCACY UPDATE & LATEST NEWS FROM CYSTIC FIBROSIS CANADA: JANUARY 8
CFCANTWAIT: ADVOCACY UPDATES Rapid Review of Trikafta In Progress Trikafta has been formally accepted for review by Health Canada and their website has been updated…
Read More
Advocacy Update & Latest News from Cystic Fibrosis Canada: December 11
#CFCANTWAIT ADVOCACY NEWS Trikafta submission update A senior Health Canada official confirmed on a CF Canada webinar that as of December 4, 2020, Health Canada…
Read More
For a lifetime of treasured moments
When living with a rare and fatal disease like cystic fibrosis (CF), simple moments of joy are extra special. As a result of generous donor…
Read More
Advocacy Update & Latest News from Cystic Fibrosis Canada: November 21
Please see below for the latest news and advocacy updates from Cystic Fibrosis Canada this week: #CFCantWait: ADVOCACY UPDATES Trikafta to be Submitted to Health…
Read More
Advocacy Update & Latest News from Cystic Fibrosis Canada: November 7
Please see below for the latest news and advocacy updates from Cystic Fibrosis Canada this week: #CFCantWait: ADVOCACY UPDATES House of Commons Standing Committee On…
Read More
Canadian Cystic Fibrosis Community in Crisis: Latest Developments as Wait for Life Changing Drug Continues
Today we respond not only to the Patented Medicine Prices Review Board (PMPRB) guidelines and the House of Commons Standing Committee on Health (HESA) motion,…
Read More
Shinerama Goes Virtual
Shinerama, Canada’s largest post-secondary fundraiser in support of Cystic Fibrosis Canada, took on a new virtual approach this year! We asked student volunteers from universities…
Read More